Resultados: 90

    The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy

    Gastroenterology; 150 (3), 2016
    "BACKGROUND & AIMS: The management of inflammatory bowel disease (IBD) poses a particular challenge during pregnancy because the health of both the mother and the fetus must be considered. METHODS: A systematic literature search identified studies on the management of IBD during pregnancy. The quality o...

    World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer

    Int. j. gynaecol. obstet; 132 (2), 2016
    "BACKGROUND: It is estimated that 1%-2% of women develop cervical intraepithelial neoplasia grade 2-3 (CIN 2-3) annually worldwide. The prevalence among women living with HIV is higher, at 10%. If left untreated, CIN 2-3 can progress to cervical cancer. WHO has previously published guidelines for strateg...

    Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline

    "OBJECTIVE: This clinical practice guideline addresses the diagnosis and treatment of primary adrenal insufficiency. PARTICIPANTS: The Task Force included a chair, selected by The Clinical Guidelines Subcommittee of the Endocrine Society, eight additional clinicians experienced with the disease, a metho...

    American Gastroenterological Association Institute Guideline on the Medical Management of Microscopic Colitis

    Gastroenterology; 150 (1), 2016
    This article has an accompanying continuing medical education activity on page e17. Learning Objective: Upon completion of this test, successful learners will be able to: (1) learn first-line treatment for the induction of remission in microscopic colitis; (2) identify the expected clinical benefi ts and...

    ACG clinical guideline: diagnosis and management of Barrett's esophagus

    Am. j. gastroenterol; 111 (1), 2016
    Barrett's esophagus (BE) is among the most common conditions encountered by the gastroenterologist. In this document, the American College of Gastroenterology updates its guidance for the best practices in caring for these patients. These guidelines continue to endorse screening of high-risk patients for...

    Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2014 U. S. Department of Veterans Affairs and U. S. Department of Defense clinical practice guideline

    Ann. intern. med; 163 (4), 2015
    DESCRIPTION: In December 2014, the U.S. Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) approved a joint clinical practice guideline for the management of dyslipidemia for cardiovascular disease risk reduction in adults. This synopsis summarizes the major recommendations. METHODS...

    Society for Maternal-Fetal Medicine (SMFM) Clinical Guideline #8: the fetus at risk for anemia: diagnosis and management

    Am. j. obstet. gynecol ; 212 (6), 2015
    OBJECTIVE: We sought to provide evidence-based guidelines for the diagnosis and management of fetal anemia. METHODS: A systematic literature review was performed using MEDLINE, PubMed, EMBASE, and the Cochrane Library. The search was restricted to English-language articles published from 1966 through May...

    Non-melanoma skin cancer in Canada chapter 1: introduction to the guidelines

    J. cutan. med. surg; 19 (3), 2015
    BACKGROUND: Non-melanoma skin cancer (NMSC), including basal and squamous cell carcinoma, represents the most common malignancy. OBJECTIVE: The aim of this document is to provide guidance to Canadian health care practitioners on NMSC management. METHODS: After conducting a literature review, the group d...

    Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care: a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine

    Intensive care med; 40 (9), 2014
    Neurocritical care depends, in part, on careful patient monitoring but as yet there are little data on what processes are the most important to monitor, how these should be monitored, and whether monitoring these processes is cost-effective and impacts outcome. At the same time, bioinformatics is a rapid...